BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6365733)

  • 1. Apocrine differentiation in lobular carcinoma of the breast: a morphologic, immunologic, and ultrastructural study.
    Eusebi V; Betts C; Haagensen DE; Gugliotta P; Bussolati G; Azzopardi JG
    Hum Pathol; 1984 Feb; 15(2):134-40. PubMed ID: 6365733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-cadherin immunohistochemical analysis of histiocytoid carcinoma of the breast.
    Gupta D; Croitoru CM; Ayala AG; Sahin AA; Middleton LP
    Ann Diagn Pathol; 2002 Jun; 6(3):141-7. PubMed ID: 12089723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Infiltrating lobular carcinoma of the breast with histiocytoid features: three cases].
    Augros M; Buénerd A; Devouassoux-Shisheboran M; Berger G
    Ann Pathol; 2004 Jun; 24(3):259-63; quiz 227. PubMed ID: 15480261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histiocytoid breast carcinoma: histological, immunohistochemical, ultrastructural, cytological and clinicopathological studies.
    Shimizu S; Kitamura H; Ito T; Nakamura T; Fujisawa J; Matsukawa H
    Pathol Int; 1998 Jul; 48(7):549-56. PubMed ID: 9701019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of benign and malignant papillary lesions of the breast.
    Papotti M; Eusebi V; Gugliotta P; Bussolati G
    Am J Surg Pathol; 1983 Jul; 7(5):451-61. PubMed ID: 6351647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytology of pleomorphic lobular carcinoma with apocrine cell differentiation of the breast. A case report.
    Tashiro T; Hirokawa M; Iuchi K; Emoto K; Tanaka T; Monobe Y; Sano T
    Acta Cytol; 2003; 47(2):265-9. PubMed ID: 12685199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR.
    Radhi JM
    Histopathology; 2000 Feb; 36(2):156-60. PubMed ID: 10672061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features.
    Mazoujian G; Pinkus GS; Davis S; Haagensen DE
    Am J Pathol; 1983 Feb; 110(2):105-12. PubMed ID: 6130702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical localization of gross cystic disease fluid protein-15, -24 and -44 in ductal carcinoma in situ of the breast: relationship to the degree of differentiation.
    Selim AA; El-Ayat G; Wells CA
    Histopathology; 2001 Aug; 39(2):198-202. PubMed ID: 11493337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast.
    Pagani A; Sapino A; Eusebi V; Bergnolo P; Bussolati G
    Virchows Arch; 1994; 425(5):459-65. PubMed ID: 7850069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical factors.
    Mazoujian G; Bodian C; Haagensen DE; Haagensen CD
    Cancer; 1989 Jun; 63(11):2156-61. PubMed ID: 2655863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The apocrine carcinoma of the breast. A cytological, immunohistochemical and ultrastructural study of 6 cases.
    Alexiev B; Boschnakova Z; Prokopanov C
    Zentralbl Pathol; 1994 Jul; 140(2):129-34. PubMed ID: 7524651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syringoid eccrine carcinoma: a case report.
    Malmusi M; Collina G
    Am J Dermatopathol; 1997 Oct; 19(5):533-5. PubMed ID: 9335248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemistry of a component protein of the breast cystic disease fluid with mol. wt 15,000.
    Le Doussal V; Zangerle PF; Collette J; Spyratos F; Hacene K; Briere M; Franchimont P; Gest J
    Eur J Cancer Clin Oncol; 1985 Jun; 21(6):715-25. PubMed ID: 3894034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoperoxidase localization of GCDFP-15 with mouse monoclonal antibodies versus rabbit antiserum.
    Mazoujian G; Parish TH; Haagensen DE
    J Histochem Cytochem; 1988 Apr; 36(4):377-82. PubMed ID: 3279111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
    Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
    Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphologic and functional aspects of apocrine metaplasia in dysplastic and neoplastic breast tissue.
    Bussolati G; Cattani MG; Gugliotta P; Patriarca E; Eusebi V
    Ann N Y Acad Sci; 1986; 464():262-74. PubMed ID: 3524352
    [No Abstract]   [Full Text] [Related]  

  • 18. Apocrine carcinoma of the breast. A morphologic and immunocytochemical study.
    Eusebi V; Millis RR; Cattani MG; Bussolati G; Azzopardi JG
    Am J Pathol; 1986 Jun; 123(3):532-41. PubMed ID: 3717305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglandular adenosis, apocrine adenosis, and tubular carcinoma of the breast. An immunohistochemical comparison.
    Eusebi V; Foschini MP; Betts CM; Gherardi G; Millis RR; Bussolati G; Azzopardi JG
    Am J Surg Pathol; 1993 Feb; 17(2):99-109. PubMed ID: 8422116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue.
    Satoh F; Umemura S; Osamura RY
    Breast Cancer; 2000 Jan; 7(1):49-55. PubMed ID: 11029771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.